Meet the Expert Panelists

This Peer Exchange™ brings together two leading experts on glucagon-like peptide-1 receptor agonists (GLP-1 RAs): Judith Hey-Hadavi, vice president of Medical Affairs at Worldwide Clinical Trials, and Nicole Snow, clinical pharmacist at Olympia Pharmaceuticals. The discussion explores the evolving landscape of GLP-1 therapy, from the shift from injectable protein-based drugs to orally available small molecules, to patient-centered dosing, safety considerations, and emerging clinical opportunities beyond diabetes and obesity.

Hey-Hadavi provides insights on the molecular and clinical rationale for small molecule development, emphasizing patient-driven demand and analytical challenges. Snow shares a clinical perspective, highlighting individualized dosing, side effect management, and integration into holistic care. Together, they illustrate the vital connection between analytical science and clinical practice in advancing GLP-1 therapies.